Ipca Laboratories, incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 17596.92 Crore) operating in Pharmaceutic...

EBITDA before forex declined 15% to Rs 262.82 crore in the third quarter of 2022 from Rs 310.83 crore posted in the same quarter of FY22. E...

At CMP, the stock is trading at 23x FY25E factoring in near term recovery.

Investec has initiated a fast buy rating on Ambuja Cement as it expects incremental disclosures on synergy and scale ambitions. "Our foreca...

Ipca Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Sale of services ...

Investors have to try and manage risks by buying into a basket of midcap pharma stocks, which is what we have been advising over the years,...

As Ipca falls over 12% following import alerts for its manufacturing units, analysts feel it will take long time for the co to resolve issu...

'Buy Ipca Labs Ltd with a target of Rs 700 and a stop loss of Rs 670'

Ipca Labs is a 'BUY' call with a target of Rs 820 and a stop loss of Rs 640.

Ipca labs is a 'BUY' call with a target of Rs 1,100 and a stop loss of Rs 770.

IPCA Labs Ltd is a ‘BUY’ with a target of Rs 800 and a stop loss of Rs 723.

Buy IPCA Labs Ltd with a target of Rs 705 and a stop loss of Rs 657: Sandeep Wagle.

Buy IPCA Labs Ltd at a stop of Rs 421.

Buy IPCA Lab Ltd at a stop of Rs 580.

IPCA Laboratories Ltd is a ‘BUY’ call with a target of Rs 545 and a stop loss of Rs 520.

Ipca Labs Ltd is a ‘BUY’ call with a target of Rs 455 and a stop loss of Rs 423.

"Ipca Labs buy with a stop of about 245."